Homocysteine in coronavirus disease (COVID-19): a systematic literature review

Giovanni Carpenè1, Davide Negrini1, Brandon M Henry2

  • 1Section of Clinical Biochemistry and School of Medicine, University of Verona, Verona, Italy.

Insights

Increased homocysteine levels may predict severe outcomes in COVID-19 patients. This systematic review suggests hyperhomocysteinemia is linked to unfavorable disease progression in coronavirus disease 2019.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Biochemistry

Background:

  • Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state.
  • Homocysteine is a potential biomarker for thrombotic diseases.

Purpose of the Study:

  • To provide an updated overview of the role of hyperhomocysteinemia in COVID-19 progression.
  • To explore the association between homocysteine levels and COVID-19 severity.

Main Methods:

  • Systematic review of studies published between 2019 and present.
  • Electronic search conducted in Medline (PubMed interface).
  • Keywords used: "COVID-19" OR "SARS-CoV-2" AND "homocysteine".

Main Results:

  • Three studies involving 694 hospitalized COVID-19 patients were included.
  • Mean homocysteine values were consistently higher in severe COVID-19 patients compared to non-severe cases.
  • A positive weight mean difference of 1.75 μmol/L (95%CI, 1.26-2.25 μmol/L; p=0.011) was observed.

Conclusions:

  • Increased homocysteine levels may serve as a predictive marker for unfavorable COVID-19 progression.
  • Further research is needed to confirm the role of homocysteine in COVID-19 outcomes.
Abstract

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.5K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
510
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213